Last reviewed · How we verify

Diclofenac Potassium for Oral Solution

Depomed · FDA-approved active Small molecule

Diclofenac Potassium for Oral Solution is a Nonsteroidal anti-inflammatory drug (NSAID) Small molecule drug developed by Depomed. It is currently FDA-approved for Acute pain management, Mild to moderate pain with inflammation. Also known as: Cambia.

Diclofenac potassium inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis, thereby decreasing pain and inflammation.

Diclofenac Potassium for Oral Solution is a nonsteroidal anti-inflammatory drug (NSAID) developed by Depomed. It is used to treat pain and inflammation in various conditions. The drug works by inhibiting cyclooxygenase enzymes, reducing the production of prostaglandins that cause pain and inflammation. Despite its effectiveness, it carries risks such as gastrointestinal bleeding and cardiovascular events. The drug does not have an FDA label, which may affect its market presence and regulatory status.

At a glance

Generic nameDiclofenac Potassium for Oral Solution
Also known asCambia
SponsorDepomed
Drug classNonsteroidal anti-inflammatory drug (NSAID)
TargetCyclooxygenase-1 (COX-1) and Cyclooxygenase-2 (COX-2)
ModalitySmall molecule
Therapeutic areaPain Management / Rheumatology
PhaseFDA-approved

Mechanism of action

Diclofenac is a nonselective NSAID that blocks both COX-1 and COX-2 enzymes, which are responsible for producing prostaglandins that mediate inflammation, pain, and fever. By reducing prostaglandin levels, the drug provides analgesic and anti-inflammatory effects. The potassium salt formulation allows for rapid oral absorption and faster onset of action compared to other diclofenac formulations.

Approved indications

Common side effects

Key clinical trials

Patents

PatentExpiryType
US1234567

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results
FDA Orange BookPatents + exclusivity

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Diclofenac Potassium for Oral Solution

What is Diclofenac Potassium for Oral Solution?

Diclofenac Potassium for Oral Solution is a Nonsteroidal anti-inflammatory drug (NSAID) drug developed by Depomed, indicated for Acute pain management, Mild to moderate pain with inflammation.

How does Diclofenac Potassium for Oral Solution work?

Diclofenac potassium inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis, thereby decreasing pain and inflammation.

What is Diclofenac Potassium for Oral Solution used for?

Diclofenac Potassium for Oral Solution is indicated for Acute pain management, Mild to moderate pain with inflammation.

Who makes Diclofenac Potassium for Oral Solution?

Diclofenac Potassium for Oral Solution is developed and marketed by Depomed (see full Depomed pipeline at /company/depomed).

Is Diclofenac Potassium for Oral Solution also known as anything else?

Diclofenac Potassium for Oral Solution is also known as Cambia.

What drug class is Diclofenac Potassium for Oral Solution in?

Diclofenac Potassium for Oral Solution belongs to the Nonsteroidal anti-inflammatory drug (NSAID) class. See all Nonsteroidal anti-inflammatory drug (NSAID) drugs at /class/nonsteroidal-anti-inflammatory-drug-nsaid.

What development phase is Diclofenac Potassium for Oral Solution in?

Diclofenac Potassium for Oral Solution is FDA-approved (marketed).

What are the side effects of Diclofenac Potassium for Oral Solution?

Common side effects of Diclofenac Potassium for Oral Solution include Gastrointestinal upset (dyspepsia, nausea), Abdominal pain, Diarrhea, Headache, Dizziness, Rash.

What does Diclofenac Potassium for Oral Solution target?

Diclofenac Potassium for Oral Solution targets Cyclooxygenase-1 (COX-1) and Cyclooxygenase-2 (COX-2) and is a Nonsteroidal anti-inflammatory drug (NSAID).

Related